免疫化学市场规模：按技术、按应用、按最终用户、按地区、范围和预测

免疫化学市场规模及预测

2023年免疫化学市场规模为33.4亿美元，预计2024年至2031年复合年增长率为7.1%，2031年达57.8亿美元。免疫化学是研究免疫系统的分子机制和反应的化学分支，特别强调抗体、抗原的结构和功能及其相互作用。结合免疫学和生物化学的原理和技术，我们对抗原如何激活免疫反应，以及抗体如何产生并发挥作用来中和感染和异物有更好的瞭解。在治疗学中，免疫化学为单株抗体的开发铺平了道路，单株抗体可用作多种疾病的标靶治疗药物，包括自体免疫疾病和恶性肿瘤。

此外，免疫化学原理在疫苗开发中发挥重要作用，可以设计出诱导免疫反应并预防传染病的疫苗。

全球免疫化学市场动态

主要市场推动因素

慢性病盛行率上升：

全球癌症、心血管疾病和自体免疫疾病等慢性疾病的增加增加了对免疫化学诊断的需求。这些诊断对于这些疾病的早期检测、监测和管理至关重要，也是市场扩张的驱动力。

技术进步：

免疫测定和抗体工程的创新提高了免疫化学测试的敏感度、特异性和速度。因此，自动化免疫分析系统和高通量筛选能力可实现更有效率、更准确的诊断过程，进而推动市场成长。

对个人化医疗的需求不断增长：

个人化医疗的转变需要根据个人的基因组成进行准确的诊断和治疗，这正在推动免疫化学市场的发展。免疫化学对于寻找生物标记和将治疗与特定患者资料相匹配非常重要。

医疗保健支出和意识不断提高：

医疗支出的增加和预防医学知识的提高正在推动免疫化学诊断在已开发国家和新兴国家的使用。鼓励早期发现疾病和健康检查的政府措施和医疗保健立法正在推动市场成长。

主要课题

先进免疫化学技术成本高：

开发和维护现代免疫化学设备和试剂成本高。这种高成本对小型实验室和医疗机构（尤其是发展中国家）构成了重大障碍，限制了尖端免疫化学诊断的采用和使用。

与替代技术的竞争：

免疫化学测试市场日益受到替代诊断技术的威胁，例如分子诊断和下一代定序，这些技术提供更快、更准确的测试。继续适应这些技术，同时保持成本效率和准确性是市场的主要障碍。

缺乏熟练的专业人员：

操作现代免疫化学设备和解释测试结果需要高技能的人员。全球范围内该领域缺乏熟练的医疗保健人员，限制了免疫化学诊断的有效使用和发展。

主要趋势

检测系统自动化与整合：

免疫化学实验室的自动化趋势正在提高效率、减少人力错误并提高生产力。包含多种诊断技术的整合系统变得越来越流行，提供全面的解决方案，加快工作流程并提高诊断准确性。

扩大即时检测 (POCT)：

在标准实验室之外提供快速结果的即时免疫化学测试的需求不断增长。此类测试在诊所、急诊室和家庭医疗机构中变得越来越普遍，从而可以更快地做出住院护理决策。

开发高灵敏度和多重检测：

免疫化学的进步使得开发更灵敏且可以同时（多重）检测多个标靶的检测方法成为可能。这提高了早期诊断疾病并以较小的样本量执行复杂分析的能力。

专注于生物标记发现和伴随诊断：

免疫化学市场越来越关注新生物标记的发现和伴随诊断的开发。这些诊断对于个人化医疗至关重要，因为它们能够根据与疾病预后和治疗效果相关的特定生物标记来客製化治疗方法。

目录

第1章简介

• 市场定义
• 市场细分
• 调查方法

第 2 章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第3章市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动力
• 市场制约因素
• 市场机会
• 波特五力分析

第4章免疫化学市场：依技术分类

• 酶联免疫吸附测定 (ELISA)
• 放射免疫分析（RIA）
• 化学发光免疫分析 (CLIA)
• 萤光免疫测定法 (FIA)
• 免疫印迹

第5章免疫化学市场：依应用分类

• 传染病测试
• 肿瘤学
• 自身免疫性疾病
• 内分泌学
• 心臟病学
• 过敏测试
• 治疗药物监测

第6章免疫化学市场：依最终用户分类

• 医院和诊所
• 诊断实验室
• 学术/研究机构
• 生物技术和製药公司
• 血库
• 护理点 (POC) 测试设施

第7章区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合酋长国

第8章市场动态

• 市场驱动力
• 市场制约因素
• 市场机会
• COVID-19 的市场影响

第9章 竞争格局

• 大公司
• 市场占有率分析

第10章 公司简介

• Roche Diagnostics（Switzerland）
• Abbott Laboratories（US）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（US）
• Danaher Corporation（US）
• Sysmex Corporation（Japan）
• Ortho Clinical Diagnostics（US）
• Bio-Rad Laboratories, Inc.（US）
• MeridianBioscience, Inc.（US）
• Fujifilm Holdings Corporation（Japan）
• LumiraDx（UK）
• QuidelOrtho Corporation（US）
• DiaSorin SpA（Italy）

第11章市场前景与机遇

• 新兴技术
• 未来市场趋势
• 投资机会

第12章附录

• 缩写表
• 来源和参考文献

Immunochemistry Market Size And Forecast

Immunochemistry Market size was valued at USD 3.34 Billion in 2023 and is projected to reach USD 5.78 Billion by 2031, growing at a CAGR of 7.1% from 2024 to 2031. Immunochemistry is a branch of chemistry that studies the molecular mechanisms and reactions of the immune system, with a special emphasis on the structure and function of antibodies, antigens, and their interactions. It combines immunological and biochemical principles and techniques to better understand how antigens activate immune responses, as well as how antibodies are created and operate to neutralize infections or foreign substances. In therapeutics, immunochemistry has led the way for the development of monoclonal antibodies that are used as targeted treatments for a variety of disorders, including autoimmune diseases and malignancies, by harnessing the body's immune system to combat the disease.

Furthermore, immunochemical principles play an important role in vaccine development, allowing for the design of vaccines that trigger an immune response and protect against infectious diseases.

Global Immunochemistry Market Dynamics

The key market dynamics that are shaping the immunochemistry market include:

Key Market Drivers

Rising Prevalence of Chronic Diseases:

The rising global frequency of chronic illnesses such as cancer, cardiovascular disease, and autoimmune disorders is driving demand for immunochemistry diagnostics. These diagnostics are crucial for the early detection, monitoring, and management of such diseases, which helps to drive market expansion.

Advancements in Technology:

Technological breakthroughs in immunoassays and antibody engineering have improved the sensitivity, specificity, and speed of immunochemistry testing. Thus, automated immunoassay systems and high-throughput screening capabilities allow for more efficient and accurate diagnostic processes, which drives market growth.

Growing Demand for Personalized Medicine:

The shift towards personalized medicine, which necessitates precise diagnosis and therapy based on individual genetic makeup, is driving the immunochemistry market. Immunochemistry is critical in finding biomarkers and adapting therapy to specific patient profiles.

Increased Healthcare Expenditure and Awareness:

Rising healthcare spending and growing knowledge about preventive healthcare in both established and emerging nations drive up the utilization of immunochemistry diagnostics. Government initiatives and healthcare legislation that encourage early disease identification and health screenings bolster market growth.

Key Challenges:

High Cost of Advanced Immunochemistry Technologies:

The development and maintenance of modern immunochemistry devices and reagents are costly. This high cost poses a substantial obstacle for small-scale laboratories and healthcare facilities, particularly in developing countries, limiting the adoption and availability of cutting-edge immunochemistry diagnostics.

Competition from Alternative Technologies:

The immunochemistry market is gradually being challenged by alternative diagnostic technologies such as molecular diagnostics and next-generation sequencing, which provide faster and more accurate testing choices. Keeping up with these technologies while being cost-effective and accurate is an enormous obstacle to the market.

Lack of Skilled Professionals:

The operation of modern immunochemistry equipment and the interpretation of test results necessitate highly skilled personnel. There is a global dearth of skilled healthcare personnel in this field, limiting the effective use and growth of immunochemistry diagnostics.

Key Trends:

Automation and Integration of Laboratory Systems:

The trend towards automation in immunochemistry laboratories is improving efficiency, lowering manual errors, and increasing productivity. Integrated systems that incorporate many diagnostic technologies are becoming increasingly popular, providing comprehensive solutions that expedite workflows and increase diagnostic accuracy.

Expansion of Point-of-Care Testing (POCT):

There is an increasing demand for point-of-care immunochemistry assays that provide quick results outside of standard laboratory settings. These tests are becoming increasingly common in clinics, emergency rooms, and home care settings, allowing for more prompt decision-making in inpatient treatment.

Development of High-Sensitivity and Multiplex Assays:

Advances in immunochemistry are enabling the development of assays with greater sensitivity and the ability to detect numerous targets at the same time (multiplexing). This improves the ability to diagnose diseases at an early stage and conduct complicated analyses with a small sample volume.

Focus on Biomarker Discovery and Companion Diagnostics:

The immunochemistry market is increasingly focused on discovering new biomarkers and developing companion diagnostics. These diagnostics are crucial for personalized medicine, as they allow for tailored treatment approaches based on specific biomarkers associated with disease prognosis and treatment response.

Global Immunochemistry Market Regional Analysis

Here is a more detailed regional analysis of the immunochemistry market:

North America:

According to Verified Market Research, North America is estimated to dominate the immunochemistry market during the forecast period. North America, particularly the United States, has a highly advanced healthcare infrastructure with extensive use of cutting-edge medical technologies. This infrastructure enables the widespread use of immunochemistry diagnostics in clinical laboratories and hospitals, contributing to the region's market supremacy.

The region's strong emphasis on R&D, which is funded by both public and commercial financing, drives innovation in immunochemistry diagnostics. This investment leads to the development of new and improved diagnostic tests and technologies, which fuels the market's expansion.

Chronic diseases such as cancer, cardiovascular disease, and autoimmune problems are prevalent in North America. The region's leadership in the immunochemistry market is mostly due to the necessity for precise and timely diagnoses to successfully manage these diseases.

Furthermore, in North America, comprehensive regulatory policies and favorable reimbursement situations ensure that sophisticated immunochemistry diagnostics are available and affordable. This motivates healthcare providers to use these technologies, boosting market growth in the region.

Asia Pacific:

The Asia Pacific region's huge and fast-growing population, along with an ageing population, considerably contributes to the rising demand for healthcare services, particularly immunochemistry diagnostics, to manage chronic and age-related disorders.

Many Asian Pacific countries are investing considerably in enhancing their healthcare infrastructure, such as expanding healthcare facilities and laboratories equipped with new diagnostic tools. This improvement is critical for increasing the accessibility and usage of immunochemistry diagnostics.

Furthermore, the region's population is becoming increasingly aware of the necessity of early disease identification and preventive healthcare. This increased awareness is pushing up demand for immunochemistry diagnostics, which are critical for early and accurate illness detection.

Europe:

European countries typically spend a significant portion of their GDP on healthcare. Government funding and support for healthcare systems, especially reimbursement rules for diagnostic tests, have a substantial impact on the regional immunochemistry market's growth.

Chronic diseases such as cancer, diabetes, and cardiovascular disease impose a huge burden on Europe. The necessity for early identification, precise diagnosis, and continued monitoring of these circumstances promotes regional demand for immunochemistry diagnostics.

Furthermore, in Europe, there is a growing movement towards personalized medicine, tailoring therapies to unique patient characteristics. Immunochemistry diagnostics are critical for finding biomarkers for personalized treatment strategies, driving their widespread usage in healthcare settings across the region.

Global Immunochemistry Market: Segmentation Analysis

The Immunochemistry Market is segmented based on Technology, Application, End-user Industry And Geography.

Immunochemistry Market, By Technology

• Enzyme-linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence Immunoassay (FIA)
• Western Blotting
• Others

Based on Technology, the market is segmented into ELISA, RIA, CLIA, FIA, Western Blotting and Others. The enzyme-linked immunosorbent assay (ELISA) segment is estimated to dominate the immunochemistry market due to its diverse uses in illness diagnosis, which include infectious disorders, cancer, autoimmune diseases, and endocrinology. It is widely used because of its specificity, sensitivity, and adaptability in detecting and measuring molecules such as peptides, proteins, antibodies, and hormones. Furthermore, ELISA's low cost, convenience of use, and capacity to process a large number of samples at once make it a popular choice for laboratories and research organizations around the world.

Immunochemistry Market, By Application

• Oncology
• Cardiology
• Endocrinology
• Allergy Testing
• Testing for Infectious Disorders
• Autoimmune Disorders
• Therapeutic Drug Monitoring
• Others

Based on Application, the market is segmented into Oncology, Cardiology, Endocrinology, Allergy Testing, Testing for Infectious Disorders, Autoimmune Disorders, Therapeutic Drug Monitoring and Others. The oncology segment is estimated to dominate the immunochemistry market during the forecast period due to the increasing global cancer incidence and the crucial need for early detection, diagnosis, and monitoring of diverse cancer kinds. Immunochemistry is essential for detecting specific cancer biomarkers, allowing healthcare practitioners to personalize treatment approaches more effectively. Furthermore, recent advancements in immuno-oncology research majorly focuses on understanding and utilizing the immune system to combat cancer, thereby, driving up demand for immunochemistry diagnostics in oncology.

Immunochemistry Market, By End-User

• Hospitals and Clinics
• Diagnostic Laboratories
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
• Others

Based on the End-User, the immunochemistry market is divided into Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies and Others. The hospitals & clinics segment is estimated to dominate the market over the forecast period. This dominance is attributed to the crucial role hospitals and clinics play in patient care, which includes diagnosis, treatment, and monitoring for various ailments. These healthcare facilities are the key points of contact for people seeking medical attention, including those who require immunochemistry testing for malignancies, autoimmune illnesses, and infectious infections.

Immunochemistry Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the immunochemistry market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the market during the forecasted period. The region, particularly the United States, has a well-established, modern healthcare infrastructure, allowing for widespread access to sophisticated diagnostic tools such as immunochemistry. North America has a significant concentration of prominent biotechnology and pharmaceutical businesses that invest heavily in R&D, fueling innovation in immunochemistry diagnostics. The region also benefits from a solid regulatory framework and significant healthcare spending, which encourages the use of sophisticated healthcare solutions.

Key Players

• The "Immunochemistry Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Abbott Laboratories, Agilent Technologies, Akoya Biosciences, AstraZeneca, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina, Leica Biosystems, Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Roche Diagnostics International Ltd, Sakura Finetek USA, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Ventana Medical Systems and Waters Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Immunochemistry Market Recent Developments
• In 2022, F. Hoffmann-La Roche dominates the South African immunochemistry market, highlighting the importance of these diagnostic instruments in healthcare.
• In March 2021, Immunochemistry Technologies (ICT) announced a collaboration with Aves Labs' family of companies. This development combines ICT's expertise in custom immunoassay services and a patented range of ELISA reagents with Aves Labs' specialized emphasis, thereby expanding their offerings in the biotech business.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Immunochemistry Market, By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence Immunoassay (FIA)
• Western Blotting

5. Immunochemistry Market, By Application

• Testing for Infectious disorders
• Oncology
• Autoimmune Disorders
• Endocrinology
• Cardiology
• Allergy Testing
• Therapeutic Drug Monitoring

6. Immunochemistry Market, By End User

• Hospitals and Clinics
• Diagnostic laboratories
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
• Blood Banks
• Point-of-Care (POC) Testing Locations

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Roche Diagnostics (Switzerland)
• Abbott Laboratories (US)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific (US)
• Danaher Corporation (US)
• Sysmex Corporation (Japan)
• Ortho Clinical Diagnostics (US)
• Bio-Rad Laboratories, Inc. (US)
• MeridianBioscience, Inc. (US)
• Fujifilm Holdings Corporation (Japan)
• LumiraDx (UK)
• QuidelOrtho Corporation (US)
• DiaSorin SpA (Italy)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References